![Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma | Nature Medicine Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01714-5/MediaObjects/41591_2022_1714_Fig1_HTML.png)
Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma | Nature Medicine
![Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study - The Lancet Respiratory Medicine Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/7487d998-e428-41a2-b40b-6826c4ecebaf/gr1_lrg.jpg)
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study - The Lancet Respiratory Medicine
![Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment - ScienceDirect Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1094553919301397-gr3.jpg)
Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment - ScienceDirect
![Long-term impact of inhaled corticosteroid use in asthma and chronic obstructive pulmonary disease (COPD): Review of mechanisms that underlie risks - Journal of Allergy and Clinical Immunology Long-term impact of inhaled corticosteroid use in asthma and chronic obstructive pulmonary disease (COPD): Review of mechanisms that underlie risks - Journal of Allergy and Clinical Immunology](https://www.jacionline.org/cms/asset/f535dd00-fef1-4646-ba34-1e5ed5855bf5/gr1.jpg)
Long-term impact of inhaled corticosteroid use in asthma and chronic obstructive pulmonary disease (COPD): Review of mechanisms that underlie risks - Journal of Allergy and Clinical Immunology
![Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study - The Lancet Respiratory Medicine Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/50dfac7f-6657-41eb-ba28-6893917f34ce/gr1_lrg.jpg)
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study - The Lancet Respiratory Medicine
![Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC today Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC today](https://today.uic.edu/wp-content/uploads/2022/02/medicine-6902841_1920-590x393.jpg)
Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC today
![Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma | European Respiratory Society Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma | European Respiratory Society](https://erj.ersjournals.com/content/erj/27/1/172/F3.large.jpg)